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1. Introduction 
The calcitonins show great differences in amino 
acid sequence between species. In the eight sequences 
so far known (human, pig, cow, sheep, eel and 
salmons I, II and III) only nine of the 32 residues are 
conserved; those at positions 1,3,4,.5,6,7,9,28 and 32. 
Surprisingly, however, the full sequence is required 
for biological activity [l] . This paper describes the 
isolation of calcitonin from the rat as the preliminary 
step to determining its sequence in order to further 
understand the relationship between structure and 
function in this hormone. Studies on the structure of 
rat calcitonin are described in the accompanying 
paper PI. 
The concentration of calcitonin in normal mamma- 
lian thyroid and fish or avian ultimobranchial glands 
is so low that large quantities of tissue must be 
collected. Medullary carcinoma of the thyroid in 
mammals is however, a tumour of the calcitonin 
producing C-cells and the cancers are extremely rich 
in the hormone [3]. Our previous isolation of human 
calcitonin [4,5] was only made practical by the use 
of such tumours in place of normal tissue. The 
discovery of medullary carcinomata of the thyroid in 
rats which contained high concentrations of calcitonin 
[6] prompted us to attempt the isolation of the 
hormone from this species for comparison with other 
known varieties. 
2. Experimental 
2.1. Isolation of rat calcitonin 
The production of second and third generation 
carcinoma explants in rats has been described else- 
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where [6]. First, second and third generation tumour 
tissue was pooled for use in this study. Finely-divided 
freeze dried tumours (8.38 g) were twice extracted 
with butanol-acetic acid-water, (150 : 1.5 : 42, by 
vol.) using 15 ml per g tissue overnight at room 
temperature and finally for 4 h using 10 ml solvent 
per g tissue. The extracts were then combined and 
dried by rotary evaporation. The sticky, brown solid 
was partitioned between 0.1 M formic acid and 
diethyl ether (approx. 25 ml of each phase per g 
original dry tissue). The ether layer was discarded and 
the aqueous layer taken and dried by rotary evapora- 
tion to give a brown solid (1.61 g) termed the crude 
extract. 
For further purification the crude extract was 
dissolved in 0.1 M formic acid (containing 10% v/v, 
propan-2-01 and 8 M urea) and chromatographed on 
a Bio Gel P-6 column (95 X 2.5 cm) using 0.1 M 
formic acid-propan-2-01 (9: 1, v/v) as eluent. Pure rat 
calcitonin was then isolated by column partition 
chromatography as described by Yamashiro [7] using 
the solvent pair butanol-pyridine-acetic acid-water 
(1000 : 96 : 16 : 1000, by vol) and Bio Gel P-10 
(100-200 mesh) as the support. Samples were 
dissolved in 400 1.11 of the upper phase of the solvent 
mixture and applied to a column (0.9 X 41.5 cm) 
previously equilibrated with both phases and then 
eluted with the upper phase collecting 500 1.11 fractions. 
2.2. Analytical methods 
Progress of the isolation was followed by either 
bioassay [8] or a radioimmunoassay for human 
calcitonin [9]. Quantitative estimations of protein 
were made by the Folin-Lowry method [ 121. 
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Thin-layer chromatography was performed on 
cellulose plates (Merck, Darmstadt, GFR) using the 
solvent butanol-pyridine-acetic acid-water, (42 : 24 : 
4 : 30 by vol). Peptide spots were located with 
ninhydrin, by a modified Reindel-Hoppe method [lo] 
or with fluorescamine [ 1 l] . 
Amino acid analyses were performed on a JEOL 
6AH instrument (JEOL Ltd., Tokyo, Japan) using a 
10 mm path-length flow-cell to increase sensitivity. 
Samples were hydrolysed with 6 M HCl in the presence 
of 10 1.18 phenol under nitrogen in sealed tubes at 
110°C for 20 h. 
Dansylation, identification of dansyl amino acids 
and dansyl-Edman degradation were carried out as 
described by Hartley [ 131. 
Enzyme digests were carried out using an estimated 
5 pg hormone and 0.1 1.18 enzyme; for thermolysin 
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20 ~10.2 M pyridine acetate pH 7.1, 16 h, 37”C, for 
trypsin 20 ~10.5 M ammonium bicarbonate, 60 min, 
37Y. 
3. Results and discussion 
Gel filtration of the crude extract of rat thyroid 
medullary carcinoma (fig.1) demonstrated two peaks 
of biological activity. They corresponded in molecular 
size to the monomeric and dimeric calcitonins found 
in extracts of human thyroid medullary carcinoma 
[4] and were therefore assumed to be monomeric 
and dimeric rat calcitonins. The dimer could be 
located only when samples were first allowed to stand 
for several hours in the assay buffer before bioassay 
in rats. This conversion of an inactive dimer to active 
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Fig.1. Gel filtration of crude extract of rat thyroid medullary carcinoma. The sample (158 mg containing 43 mg protein) was 
added to 3.0 g urea, 0.6 ml propan-2-01 and 1 ~1 mercaptoethanol, made up to 6.0 ml total volume with 0.1 M formic acid and 
chromatographed on a Bio Gel P-6 (200-400 mesh) (95 X 2.5 cm) column using 0.1 M formic acid-propan-2-01, (9: 1, v/v) as 
eluent. Fractions of 6.0 ml were collected. The continuous line shows the protein content per fraction and the histogram shows 
the two biologically active regions; D = dimeric, M = monomeric rat calcitonins. 
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Fig.2. Partition chromatography of monomeric rat calcitonin 
purified by gel filtration. Two peaks of calcitonin were 
detected by the radioimmunoassay for human calcitonin 
(solid line). Superimposed on this graph is a t.1.c. analysis of 
a sample from each fraction. Selected Rf values are shown in 
the right-hand axis; on the same plate human calcitonin ran 
at Rf 0.75 and bovine insulin at Rf 0.57. The two peaks of 
immunological activity coincide with pure peptides. 
monomer is also observed with human calcitonin 
dimer [ 141 and dogfish calcitonin dimer [ 151 and is 
presumed to represent reduction by the free thiol 
group of bovine serum albumin present in the assay 
buffer. Calcitonin dimers are formed by rearrange- 
ment of the intrachenic disulphide bonds to interchain 
links [20]. 
n.d. = not determined. 
After reduction with 4 M mercaptoethanol of all 
dimeric hormone to the monomeric form and its 
subsequent rechromatography, all monomeric rat 
calcitonin was pooled and fractionated by partition 
chromatography (fIg.2). The fractions from the column 
were analysed by radioimmunoassay and t.1.c. but 
prptein estimations were not made in order to 
conserve material. It is evident that two immuno- 
reactive peptides were eluted from this column both 
of which appeared homogenous on t.1.c. In further 
examination both peptides gave the same amino acid 
composition after acid hydrolysis and the same 
tryptic and thermolytic peptide patterns on one- 
dimensional t.1.c. It is likely, therefore, that they both 
have the same sequence but the modification respon- 
sible for the difference in polarity remains unknown. 
those for human calcitonin. The provisional values 
reported by Burford et al. [ 161 are also similar to 
our present values. However, the inability of these 
workers to assign whole residue numbers for some 
amino acids must reflect a degree of impurity in 
their preparation. 
Following oxidation with performic acid, dansyla- 
tion revealed cysteic acid as the amino terminal 
residue. This is characteristic of all other known 
calcitonins. 
The biological potency of rat calcitonin was not 
determined rigourously but estimated to be of the 
order of a few hundred MRC units per mg in common 
with other mammalian species; Burford et al. reported 
400 MRC U/mg [ 161. The biological activity was 
destroyed on mild oxidation with hydrogen peroxide 
as is the case with human calcitonin where the 
methionine residue at position 8 is oxidised to its 
sulphoxide. pig and salmon calcitonln are not affected 
in this way. 
The amino acid composition of rat calcitonin is Several publications have reported the cross- 
given in table 1. Except for cystine, which was not reaction of rat calcitonin in radiolmmunoassays for 
determined, the residue numbers are very similar to human calcitonin [16,17,18]. We confirm this and 
Table 1 
Amino acid composition of rat calcitonin 
Amino acid Residues per mole peptide 
(average of 3 values) 
Integer value 
(human) 
LYS 0.9 1 (1) 
His 1.1 1 (1) 
Arg 0 0 (0) 
Asx 2.6 3 (3) 
Thr 4.0 4 (5) 
Ser 2.0 2 (1) 
Glx 2.4 2 (2) 
PI0 2.4 2 (2) 
GlY 3.9 4 (4) 
Ala 1.6 2 (2) 
% (CYS), n.d. 2a (2) 
Val 1.1 1 (1) 
Met 0.8 1 (1) 
Be 1.0 1 (1) 
Leu 2.9 3 (2) 
Tyr 0.8 1 (1) 
Phe 2.0 2 (3) 
a N-terminal half-cystine shown by dansylation and the 
second residue assumed by analogy with all other calcitonins. 
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Fig.3. Comparison on a molar basis of the reaction of rat (0) 
and human (n) calcitonins with an anti-human calcitonln 
antiserum (336/6) at a final dilution of 1:24 000) using InsI- 
human calcitonin as tracer. Human calcitonin was the MRC 
synthetic standard 70/50 and rat calcitonin was quantitated 
by amino acid analysis. 
have been able to use the human calcitonin radio- 
immunoassay to follow the progress of isolation of 
the rat hormone. A direct comparison on a molar 
basis for the reaction of pure rat and human calcitonins 
with antiserum 336/6 at a final dilution of 1 : 24 000 
is shown in Iig.3. Rat calcitonin appears to reach the 
same maximum displacement of r2%human 
calcitonin from antibody but only when present in 
approx. lo-fold higher molar concentration. This 
degree of cross-reaction clearly demonstrates a. large 
degree of sequence homology between rat and human 
calcitonins, at least in the region of the binding site 
which is at the C-terminus for this particular anti- 
serum [19]. 
This work shows the importance of medullary 
carcinoma of the thyroid as a general source tissue in 
the isolation of calcitonins. The concern that peptides 
from tumours may not have the natural sequence isto 
some extent supported by the fact that rat calcitonin 
and human calcitonin (both isolated from tumours) 
are similar to each other but dissimilar to all other 
known calcitonins. However the provisional amino 
acid composition reported by Burford et al. [ 161 
for rat calcitonin from normal thyroid tissue is broadly 
in agreement with our results for tumour-derived rat 
calcitonin. It seems likely, therefore, that ‘normal’ and 
‘tumour’ rat calcitonin are identical. 
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